VASAPOLLO, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 7.820
AS - Asia 2.139
EU - Europa 1.610
SA - Sud America 321
AF - Africa 33
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 11.936
Nazione #
US - Stati Uniti d'America 7.748
SG - Singapore 1.241
IT - Italia 536
CN - Cina 352
BR - Brasile 259
RU - Federazione Russa 234
VN - Vietnam 166
DE - Germania 142
HK - Hong Kong 124
IE - Irlanda 115
PL - Polonia 102
FR - Francia 96
FI - Finlandia 80
UA - Ucraina 75
GB - Regno Unito 70
JP - Giappone 66
NL - Olanda 63
CA - Canada 44
SE - Svezia 38
IN - India 31
AR - Argentina 26
BD - Bangladesh 24
ID - Indonesia 21
KR - Corea 19
MX - Messico 19
CZ - Repubblica Ceca 17
IQ - Iraq 17
TR - Turchia 16
ES - Italia 12
PK - Pakistan 10
ZA - Sudafrica 10
AU - Australia 9
EC - Ecuador 9
NP - Nepal 9
VE - Venezuela 8
BE - Belgio 7
IL - Israele 6
CO - Colombia 5
IR - Iran 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
KE - Kenya 4
SA - Arabia Saudita 4
AT - Austria 3
BO - Bolivia 3
HU - Ungheria 3
PY - Paraguay 3
RS - Serbia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
GT - Guatemala 2
JO - Giordania 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
PS - Palestinian Territory 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.936
Città #
Woodbridge 1.699
Wilmington 1.680
Houston 1.525
Singapore 463
San Jose 245
Fairfield 240
Ashburn 221
Chandler 184
Ann Arbor 159
Rome 124
Council Bluffs 119
Hong Kong 119
Dublin 115
Beijing 110
New York 94
Kraków 93
Seattle 90
Cambridge 87
Los Angeles 76
The Dalles 63
Medford 62
Ho Chi Minh City 60
Helsinki 56
Tokyo 54
Zhengzhou 52
Dearborn 50
Jacksonville 50
Santa Clara 44
Milan 43
Dallas 40
Hanoi 40
Boardman 38
Cedarhurst 33
Moscow 30
São Paulo 29
Lawrence 28
North Bergen 26
Buffalo 24
Lauterbourg 24
Chicago 23
Redondo Beach 21
Naples 19
Monte Vista 18
Florence 17
San Diego 16
Olomouc 15
Amsterdam 14
Frankfurt am Main 14
Phoenix 14
Montreal 13
Shanghai 13
Bologna 12
Utrecht 12
Vancouver 12
Boston 11
Munich 11
San Francisco 11
Atlanta 10
London 10
Orem 10
Palermo 10
Salt Lake City 10
Stockholm 10
Brooklyn 9
Dhaka 9
Rio de Janeiro 9
Turin 9
Ascoli Piceno 8
Lappeenranta 8
Manchester 8
Melbourne 8
Mülheim 8
Baghdad 7
Brussels 7
Chennai 7
Denver 7
Guangzhou 7
Poplar 7
Redwood City 7
Ankara 6
City of London 6
Johannesburg 6
Quito 6
Warsaw 6
Augusta 5
Belo Horizonte 5
Campinas 5
Changsha 5
Curitiba 5
Da Nang 5
Genoa 5
Manaus 5
Mexico City 5
Ninh Bình 5
Querétaro 5
Suzhou 5
Tel Aviv 5
Toronto 5
Baku 4
Detroit 4
Totale 8.848
Nome #
Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function 545
Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications 523
Body composition during normal pregnancy: reference ranges 519
Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction 504
Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies 496
Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia 477
Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: Relationship to placenta-related complications of pregnancy 469
Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery 432
Maternal total vascular resistance and concentric geometry: A key to identify uncomplicated gestational hypertension 429
The computerized fetal heart rate analysis in post-term pregnancy identifies patients at risk for fetal distress in labour 424
Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients 394
Nifedipine-induced changes in body composition in hypertensive patients at term 388
Total body water estimation and maternal cardiac systolic function assessment in normal and gestational hypertensive pregnant women 358
Maternal body composition at term gestation and birth weight: is there a link? 357
Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women 350
Foetal heart rate deceleration with combined spinal-epidural analgesia during labour: A maternal haemodynamic cardiac study 271
Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Pre-Eclampsia and Italian Society of Perinatal Medicine 218
Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders 192
Fetal growth restriction and maternal cardiac function 187
Maternal hemodynamics early in labor: a possible link with obstetric risk? 185
Early and Late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease 181
Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics 165
Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind? 161
Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth 152
Friendly help for clinical use of maternal hemodynamics 151
Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy? 149
Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure 145
Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent preeclampsia 144
Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True? 143
Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics 129
Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction 129
Prenatal and postnatal imaging of multiple intracranial lipomas: Report of a Case 114
Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction 109
The “Preeclampsia and Hypertension Target Treatment” (“PYTT”) study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings 106
Cardiac Function 103
Systemic vascular resistance may influence the outcome of in vitro fertilization 100
Are Chlamydia Trachomatis and Neisseria Gonorrhoeae Screenings in Pregnant Women Being Properly Performed? A Single-Center Retrospective Observational Study in Italy 100
Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study 97
D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients 89
Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction 85
Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM) 85
G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 84
Definition, identification, implications and management of hypodynamic hypertension in pregnancy 82
F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy? 80
Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction 76
Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction 74
C-peptide and insulin levels at 24-30 weeks' gestation: An increased risk of adverse pregnancy outcomes? 71
G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles 71
Restricted physical activity and maternal rest improve fetal growth: should we look for the reason in the cardiovascular modifications? 67
SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia 66
Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies 66
Maternal hemodynamics in early and late fetal growth restriction 65
NO donors on top of anti-hypertensive therapy reduces complications in chronic hypertensive pregnancies with hypodynamic circulation 61
Pre-eclampsia: One name, two conditions - The case for early and late disease being different 59
Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 59
Longitudinal maternal hemodynamic evaluation in uncomplicated twin pregnancies according to chorionicity: physiological cardiovascular dysfunction in monochorionic twin pregnancy 57
Maternal cardiac systolic and diastolic function: Relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study 57
Computerized evaluation of fetal heart rate during tocolytic treatment: Comparison between atosiban and ritodrine 55
F4. NO donors and haemodynamic changes in fetal growth restriction 55
Total vascular resistance and left ventricular morphology as screening tools for complications in pregnancy 52
Left ventricular concentric geometry as a risk factor in gestational hypertension 51
Intrauterine growth restriction and fetal body composition 50
ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction 47
L18. Total Vascular Resistance in complicated pregnancies 46
The cardiac-fetal-placental unit: fetal umbilical vein flow rate is linked to the maternal cardiac profile in fetal growth restriction 45
Nitric oxide donor increases umbilical vein blood flow and fetal oxygenation in fetal growth restriction: A pilot study 44
Maternal diastolic dysfunction and left ventricular geometry in gestational hypertension 44
The impact of maternal cardiovascular status prior to labor on birth outcomes: an observational study 43
Umbilical venous flow and maternal hemodynamics as predictors of impaired fetal growth in gestational diabetes: a prospective study 41
The role of umbilical vein blood flow assessment in the prediction of fetal growth velocity and adverse outcome: a prospective observational cohort study 40
Maternal cardiovascular haemodynamics in normal and complicated pregnancies 39
Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome 38
Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: A pilot study 36
Individualized maternal positioning to optimize cardiac output and placental perfusion 8
Physical exercise improves cardiovascular function after preeclampsia and reduces the risk of recurrent preeclampsia in the subsequent pregnancy: an echocardiographic prospective cohort study 7
null 4
null 3
Totale 12.198
Categoria #
all - tutte 33.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 54 40 10
2021/2022305 13 57 16 14 12 10 17 13 14 38 24 77
2022/2023554 98 49 19 54 41 111 44 43 55 12 22 6
2023/2024208 18 2 4 8 8 60 12 7 4 10 2 73
2024/20252.041 17 184 100 45 14 335 259 115 190 112 384 286
2025/20262.968 226 136 352 361 334 174 356 456 311 262 0 0
Totale 12.198